Clinical Trial

Study of ZG006 in Participants With Neuroendocrine Prostate Cancer

Name: Study of ZG006 in Participants With Neuroendocrine Prostate Cancer — clinical trial record (NCT07024277)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multicenter, open-label Phase II study, aimed at exploring the preliminary efficacy and safety of ZG006 in patients with advanced metastatic NEPC who have previously failed standard treatment.

Trial Details

NCT Number	NCT07024277
Lead Sponsor	Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Conditions	Neuroendocrine Prostate Cancer
Enrollment	60 participants
Start Date	2025-08
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-06-17